Community Oncology Files Amicus Brief with Supreme Court Supporting State Regulation of PBMs

COA and Practices Strongly Support Right of States to Step Up and Do What is Right for Vulnerable Patients

Arkansas and other states must be allowed to do what is right for vulnerable patients by regulating PBMs.”

— Ted Okon, executive director of COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, March 3, 2020 /EINPresswire.com/ — The Community Oncology Alliance and several leading community oncology practices filed an Amicus Curiae brief with the Supreme Court this week supporting the rights of states to regulate Pharmacy Benefit Managers (PBMs).

In the brief, community oncology strongly supports the need for states to be able to stop PBM abuses, especially those that are hurting patients with cancer. In recent years, PBMs have increasingly inserted themselves between oncologists and their patients, adversely impacting the delivery of cancer care.

“The constitution is clear that elected officials at the state level have a duty and authority to enact policies to protect the health and well-being of their citizens. Unfortunately, inaction by Congress and misguided policy by this administration have allowed PBMs to increasingly dominate our cancer care system. We applaud all the states stepping up to stop PBM abuses,” said Ted Okon, executive director of COA. “PBMs have been nothing but a plague for cancer patients, who face delays and denials in accessing their life-saving medications. Arkansas and other states must be allowed to do what is right for vulnerable patients by regulating PBMs.”

Read COA’s Amicus Curiae brief in Rutledge v. the Pharmaceutical Care Management Association.

The case before the Supreme Court is Rutledge v. the Pharmaceutical Care Management Association, and it is set to be heard in late April. The Arkansas Attorney General is Leslie Rutledge and the PCMA is the professional lobbying group that represents PBMs. The PCMA sued the state of Arkansas after it found that PBMs were violating the state’s Deceptive Trade Practices Act, reimbursing pharmacies below the pharmacies’ cost to acquire the medication.

The details of this case and news stories about PBMs typically focus on the adverse financial impact of PBMs on pharmacy providers, which the community oncology brief does as well. However, the brief also informs the court how “low-ball” reimbursement tactics are being used by PBMs to steer business to their own mail-order pharmacies, which is adversely impacting patient care. COA collects reports of real-life patient horror stories at the hands of PBMs and the suffering they cause by delaying delivery of critical cancer drugs, denying coverage, and arguing with physicians over proper treatment, among other abuses. These include PBM horror stories like those published in the Fresno Bee, Columbus Dispatch and STAT News.

Although Congress is considering legislation to regulate PBMs’ bad behavior, the Administration has actually given PBMs more power, instead of less. These include dangerous practices like “fail-first” step therapy and formulary restrictions, which oncologists know don’t work and actually harm patients. Community oncology has been warning that without significant state or federal action, PBM abuses will undermine the incredible, lifesaving progress the United States has made in treating cancer and reducing mortality due to the disease.

COA and community oncology practices are actively working to address the high cost of cancer drugs and services. As the frontline providers of care for the majority of Americans battling cancer, independent community oncologists are uniquely positioned to give insight into the real-world impact of policymaking on patients, providers, and the overall health care system. Community oncology practices that joined COA in this brief include Florida Cancer Specialists & Research Institute; New York Cancer and Blood Specialists; Regional Cancer Care Associates; Tennessee Oncology; Texas Oncology; and the Quality Cancer Care Alliance.

Read COA’s Amicus Curiae brief in Rutledge v. the Pharmaceutical Care Management Association at https://communityoncology.org/wp-content/uploads/2020/03/18-540tsacCommunityOncologyAllianceInc.pdf

Nicolas Ferreyros
Community Oncology Alliance
+1 2027298147
email us here


Source: EIN Presswire

Stem Cell Therapy for Coronavirus Infection

Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant.

Vitro Diagnostics Inc. (OTCMKTS:VODG)

We are pleased to be positioned to offer stem cell therapy for Coronavirus infection.”

— Dr. James Musick

GOLDEN, COLORADO, UNITED STATES, March 3, 2020 /EINPresswire.com/ — Stem Cell Therapy for Coronavirus Infection

GOLDEN, CO,March 3 2020 /Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant. While this therapy is not a method to eradicate or cure Coronavirus, there is evidence to support the concept that infected patients may be more likely to combat and survive infection. First, stem cells resist viral attack by the expression of certain genes known as interferon gamma stimulated genes (ISGs). These are expressed in stem cells prior to their differentiation. (Wu, X, et al, Cell 172: 423, 2018). Hence, stem cells would be expected to survive even if transplanted into a patient with an active Coronavirus infection. Also, it is known that stem cells rejuvenate and regenerate cells in the body through various processes involving reduction of inflammation, secretion of substances that protect cells, transfer of mitochondria, reduction of cell death, anti-oxidative effects and improvement of immune system function. These effects are likely to increase survival in patients infected with Coronavirus. Also, there is direct evidence of stem cell protection against viral infection. Influenza virus A/H5N1 causes acute lung injury that was reduced by human mesenchymal stromal cells (MSCs) in mice and the treatment increased survival (Chan, et al, PNAS 113:3621, 2016).

Vitro Biopharma has operated a highly regulated, FDA-compliant commercial biologics manufacturing facility for several years and is cGMP compliant, ISO9001 Certified, ISO13485 Certified, CLIA Certified and FDA registered. All clinical manufacturing occurs in a certified sterile clean room with extensive and advanced testing to assure the absence of contamination. Furthermore, in numerous patients treated to date by IV infusion of our AlloRx Stem Cells™ there have been no significant adverse events while we have gained evidence of efficacy. We presently supply our AlloRx™ Stem Cells to DVC Stem in the Cayman Islands for treatment of inflammatory conditions. We plan to begin recruitment of patients for a trial of stem cell therapy of musculoskeletal conditions in the Bahamas during spring 2020.

Dr. Jim Musick, CEO said, "We are pleased to be positioned to offer stem cell therapy for Coronavirus infection. While there are several factors related to the possible extent of this global infection, stem cell therapy represents a therapeutic option to fight the virus and increase survival while effective vaccines are being developed. Our existing off-shore partners offer stem cell transplant services and we are in contact with CDC officials regarding potential US-based stem cell transplants into infected individuals."

About Vitro Biopharma

Vitro Biopharma, for over 10 years, has supplied major biopharmaceutical firms, elite university laboratories and clinical trials worldwide with Mesenchymal Stem Cells, the MSC-Grow™ Brand of cell culture media, various stem cell derivatives and stem cell-derived differentiated cells. We also manufacture primary fibroblast cells and an expanding line of cancer-associated fibroblasts (CAFs) from various tumors including lung, breast, melanoma, pancreatic, glioblastoma and colorectal tissues. Our CAFs are purchased by major pharmaceutical and biopharmaceutical firms to advance immunotherapy of cancer.

Out of our years of research, we developed our patent-pending and proprietary line of umbilical cord-derived stem cells AlloRx™ Stem Cells now being used in offshore regenerative medicine clinical trials. Our stem cells are used in regenerative medicine clinical trials with our partner in the Cayman Islands www.DVCStem.com. We have a recently approved clinical trial using our AlloRx™ Stem Cells to treat musculoskeletal conditions at The Medical Pavilion of the Bahamas www.tmp-bahamas.com in Nassau. We are supporting clinical studies of stem cell therapies using our AlloRx™ Stem Cells for osteoarthritis, neurodegenerative diseases including Parkinson's disease, Multiple Sclerosis and Alzheimer's disease while pursuing select US markets for stem cell therapies.

We support our regenerative therapies with NutraVivo™/STEMulize™, a nutraceutical Stem Cell Activator that has been shown to induce proliferation, migration and epigenetic modification of human adult stem cells. NutraVivo™ improves overall cellular wellness and significantly increases expression of anti-aging genes.

Forward-Looking Statements

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company's auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain "forward-looking statements". Such forward-looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Dr. James Musick
Chief Executive Officer
Vitro Biopharma
(303) 999-2130 Ext. 1
E-mail: jim@vitrobiopharma.com

SOURCE: Vitro Diagnostics, Inc.

John Evans
Vitro BioPharma
+1 303-601-7855
email us here


Source: EIN Presswire

Lawyer Nicholas Hicks Explains the Benefits of Divorce Mediation

According to Nicholas Hicks, it’s possible to skip litigation and make your divorce process simpler.

BUFFALO, NY, USA , March 3, 2020 /EINPresswire.com/ — If you are starting a divorce, you already know that the process is not simple and straightforward. When a marriage has reached its end, parties must decide how their debts and assets should be split. Another big topic is determining who will have primary custody over the children. However, lawyer Nicholas Hicks notes that some divorce strategies are better than others.

For those couples who are on good terms and would like to avoid litigation, lawyer Nicholas Hicks recommends seeking divorce mediation. The process allows the pair to talk about achievable outcomes and negotiate things like spousal support, child support, equitable distribution and more in a controlled environment. It can make divorce seem more manageable and less overwhelming.

Lawyer Nicholas Hicks explains that divorce mediation is intended to be a faster, more relaxed process for handling divorce. Many people don’t even realize it’s an option until they ask their attorney about alternative methods for dispute resolution. Some couples already know precisely what they want, while others need to be guided through the decision making process. Either way, the divorce mediator will be there for support.

One of the biggest perks to divorce mediation is its flexibility. Lawyer Nicholas Hicks explains that some parties are ready to talk together right away. Others may want to meet individually with the mediator to build trust and rapport before the full mediation sessions begin. Preliminary planning can help many feel more confident about what they want out of the negotiation. Plus, couples have more flexibility in the outcome, as there is no need for the courts to take control and implement outside orders.

Lawyer Nicholas Hicks notes that the beauty in these sessions is that they can be as straightforward or emotional as the couple desires. Sometimes deeply rooted problems can come to the surface, and meaningful conversations can be had. Other times, divorce mediation can quickly address the main concerns of child custody, alimony, and divorce grounds according to the rules of New York law.

No matter which route you choose, just know that you are in charge of creating a divorce mediation experience that works for you. However, the more information your divorce mediator has about your situation, the better they can help you plan for the future. Don’t be surprised if, after the session, you find yourself thinking about things differently or feel a change of heart on various issues. Instead of being pushed apart in the court system, the couple must come together despite their differences to make the most moving forward.

If you have any questions, please contact your legal attorney for help in your specific case.

About Lawyer Nicholas Hicks:

Nicholas Hicks was rescued from NYC foster care as a child at the age of 5 years old. Lawyer Nicholas Hicks attended both public and private schools where he eventually graduated from ECC, UB & UB Law School. He specializes in various areas of practice, including injury cases, debt elimination, criminal defense, divorce, child support, child custody, and more.

Caroline Hunter
Web Presence, LLC
+1 7862338220
email us here


Source: EIN Presswire

Animal Wellness’ Marty Irby to Present Equine Protection Initiatives in Western New York Next Week

Animal Wellness Action Executive Director Marty Irby

Animal Wellness Action Executive Director Marty Irby

Marty Irby and President Donald Trump at the signing of the PACT Act in November

Marty Irby and President Donald Trump at the signing of the PACT Act in November

Marty Irby and Richie Sambora at The Breeders’ Cup in 2017 at Del Mar

Marty Irby, Speaker Nancy Pelosi, and Holly Gann in July

Marty Irby, Speaker Nancy Pelosi, and Holly Gann in July

Marty Irby and Priscilla Presley lobbying for passage of the PAST Act in January

Marty Irby and Priscilla Presley lobbying for passage of the PAST Act in January

I applaud the equine advocates in Western N.Y. who have worked tirelessly to help advance federal policies that will protect our iconic American horses – whose very backs this country was built upon.”

— Marty Irby, executive director at Animal Wellness Action

BOSTON, NEW YORK, USA, March 3, 2020 /EINPresswire.com/ — On Saturday March 14, 2020, Animal Wellness Action’s Executive Director, Marty Irby, will present the portfolio of federal equine protection initiatives currently before the U.S. Congress at Equine Collaborative International’s Spring Kickoff. This is the third year in a row Irby has presented the federal update in the region. The Spring Kickoff will be held from 9:00 AM – 4:00 PM at Faith United Church of Christ located at 8651 Boston State Road just outside of Buffalo.

Other presenters include Jim Miller with Green Mountain Nutritional Services, Emma Minteer with Mustangs Empowering Women, Dr. Cindy Lankenau, trainer Megan Mangold, Steven Stevens, and Amber Roberts.

“I’m honored and grateful to have the opportunity to speak at Equine Collaborative International’s Spring Kickoff again this year, said Marty Irby, executive director at Animal Wellness Action, and a former 8-time world champion equestrian rider. “I applaud the equine advocates in Western New York who have worked tirelessly to help advance federal policies that will protect our iconic American horses – whose very backs this country was built upon.”

Irby is a life-long horseman, former president of the Tennessee Walking Horse Breeders’ & Exhibitors’ Association, and former Communications Director in the U.S. House of Representatives whose written works on equine protection have been published in USA Today, The Hill, Albany Times-Union, The Washington Examiner, The Daily Caller, The Chicago Daily Herald, Louisville Courier-Journal, Pennsylvania Capital-Star, Horse Nation, and numerous other outlets across the country. He was named by The Hill as one of the Top Lobbyists for 2019 and resides in Washington, D.C.

Irby will be presenting updates on the following issues:

The Horseracing Integrity Act, H.R. 1754/S. 1820 introduced by U.S. Reps. Paul Tonko, D-N.Y., and Andy Barr, R-Ky., in the U.S. House, and U.S. Senators Kirsten Gillibrand (D-N.Y.) and Martha McSally (R-Ariz.) in the U.S. Senate.

The Prevent All Soring Tactics Act (PAST), H.R. 693/S. 1007 introduced by U.S. Reps. Kurt Schrader, D-Ore., and Ted Yoho, R-Fla., in the U.S. House, and U.S. Senators Mike Crapo R-Idaho, and Mark Warner, D-Va., in the U.S. Senate.

The Safeguard American Food Exports (SAFE) Act, H.R. 961/S. 2006, introduced by U.S. Reps. Jan Schakowsky, D-Ill., and Vern Buchanan, R-Fla., in the U.S. House and U.S. Senators Lindsay Graham, (R-S.C., and Bob Menendez, D-N.J., in the U.S. Senate.

The Wild Horse and Burro management, round-up, and fertility, and incarceration plans underway by the Federal Bureau of Land Management.

Enforcement of the Horse Protection Act of 1970 by the United States Department of Agriculture under the leadership of Secretary Sonny Perdue.

For more information on Equine Collaborative International’s Spring Kickoff please contact Barbara Moore at 411eci@gmail.com or 716-912-2100.

The Animal Wellness Foundation (Foundation) is a Los Angeles-based private charitable organization with a mission of helping animals by making veterinary care available to everyone with a pet, regardless of economic ability. We organize rescue efforts and medical services for dogs and cats in need and help homeless pets find a loving caregiver. We are advocates for getting veterinarians to the front lines of the animal welfare movement; promoting responsible pet ownership; and vaccinating animals against infectious diseases such as distemper. We also support policies that prevent animal cruelty and that alleviate suffering. We believe helping animals helps us all.

Animal Wellness Action (Action) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that’s why we remind voters which candidates care about our issues and which ones don’t. We believe helping animals helps us all.

Marty Irby
ANIMAL WELLNESS ACTION
2028215686
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Content Delivery Networks Market: Global Share, Size, Trends and Growth Analysis Forecast to 2020-2024

Content Delivery Networks -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, March 3, 2020 /EINPresswire.com/ — Content Delivery Networks Industry

Description

Content delivery networks (CDNs) are a group of edge servers that are spread across the globe at strategic locations. These severs accelerate websites and deliver content/data optimally, quickly and safely. The edge servers of a CDN contain duplicate content of the originating network. CDNs dynamically provide data to clients by calculating which server is located close to the client and content is delivered based on these calculations.

The global market for content delivery network reached $11.5 billion in 2019 and should reach $34.3 billion by 2024, at a compound annual growth rate (CAGR) of 24.5% for the period of 2019-2024. CDNs were previously considered applicable only to large companies because of their high cost. Over the last few years, due to the changing form and trends of digital content, smaller companies are deploying these solutions. Currentday CDNs are more efficient, cheaper and have the capability to work for almost all websites on the internet.

In this report, the global CDN market is segmented by solution type, service provider type, organization size and application. Based on solution type, the CDN market is segmented into media delivery, web performance optimization, monitoring and analytics, data security and cloud storage and others. The media delivery solutions segment accounted for the largest share of the market in 2018 and is expected to maintain dominance over the forecast period. The media delivery solution segment has been flourishing in the CDN market as video transport moves from specialized cable, satellite or terrestrial networks to the internet. Also, rise in internet video services such as Netflix, Hulu, Amazon and others
have largely contributed to the growth of the media delivery solutions segment in the CDN market. The fastest growing solution segment in the CDN market is the data security and cloud storage segment, which is expected to grow at a CAGR of REDACTED during the forecast period.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4497753-content-delivery-networks-global-markets

The global CDN market segmented by service provider type is categorized into peer-to-peer CDN, cloud CDN, traditional CDN and others. Traditional CDNs accounted for the largest share of the market in 2018 (valued at REDACTED billion). The market for traditional CDN is expected to grow at a CAGR of REDACTED and is forecast to reach REDACTED billion by 2024. Traditional CDNs are content delivery networks wherein the datais duplicated across multiple PoPs. Based on user location, the PoP located closest to the user willdeliver the page to reduce latency. The fastest growing category by serviceprovider type is the cloudCDN segment, which is expected to grow at a CAGR of REDACTED and is forecast to reach REDACTED billion by 2024, up from REDACTED billion in 2018. Cloud CDNs, unlike traditional CDNs, are hosted in private datacenters and take advantage of geographic availability on the pay-as-you-go model.

The CDN market by application is categorized into: banking, finance and insurance (BFSI), media and entertainment, gaming, retail and e-commerce and others. The media and entertainment segment accounted for the largest share of the market in 2018 and was estimated to be $4.0 billion. CDNs for the media and entertainment segment are expected to grow at a CAGR of REDACTED and forecasted to reach REDACTED billion by 2024. CDNs in the media and entertainment sector, improve network traffic and enable companies to deliver content to a large number of users, simultaneously. The fastest growing application segment in the CDN market is the gaming sector, which is expected to grow at a CAGR of REDACTED and is projected to reach REDACTED billion by 2024. Increasing global demand for online multi-player gaming and demand for content protection is driving the demand for CDNs in the gaming sector.

Report Scope:

In this report, the market has been segmented based on solutions, service provider type, organization size, applications and geography. The report provides an overview of the global market for CDNs and analyzes market trends. Using 2018 as the base year, the report provides estimated market data for the forecast period 2019-2024. Revenue forecasts for this period are segmented based on solution type, service provider type, organization size and applications and geography. Market values have been estimated based on the total revenue of CDN providers.

The report covers the market for CDNs with regard to applications in various sectors across different geographic regions. It also focusses on the major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for CDNs in 2018 and provides projections of the expected market size through 2024.

Report Includes:

– 49 data tables and 41 additional tables
– An overview of global content delivery network market
– Analyses of global market trends, with data from 2018, estimates of 2019, and projections of compound annual growth rates (CAGRs) through 2024
– Characterization and quantification of content delivery network market by solution, by service provider, by organization size and by application
– Identification of market drivers, restraints and other forces impacting the global content delivery network market
– Details about various solutions of content delivery networks in different application sectors
– Company profiles of leading market participants within the industry, including Alphabet Inc., Amazon.com, Inc., Cloudflare, Inc., Equinix, Inc., Imperva, Microsoft Corp., StackPath, LLC and Swarmify Inc.

Akamai Technologies
Alphabet Inc. (Google Inc.)
Amazon Web Services (Amazon.Com, Inc.)
Cdnetworks. Inc.
Centurylink, Inc. (Level 3 Communications Llc)
Chinacache International Holdings Ltd.
Chinanetcenter Co.
Cloudflare, Inc.
Comcast Technology Solutions
Equinix, Inc.
Imperva
Limelight Networks, Inc.
Microsoft Corp.
Netstairs, Inc.
Rackspace Us, Inc.
Scientiamobile, Inc.
Stackpath, Llc
Swarmify, Inc.
Total Server Solutions
Varnish Software Ab
Vecima Networks (Concurrent Computer Corp.)

Continued…

Leave a Query @ https://www.wiseguyreports.com/enquiry/4497753-content-delivery-networks-global-markets

Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Redemption Cannabis Brands Launch Highlighted in Revolutionary New Video Series

Ryan Basore

Ryan Basore, CEO, Redemption Cannabis

Ryan Basore and Gage Cannabis

Ryan Basore receives a social equity grant from Gage Cannabis Company

Logo for Redemption Cannabis

Redemption Cannabis Company

Video series explores cultivators and processors behind Michigan's Redemption Cannabis product line; videos feature host Ryan Basore, director Rick Thompson

I was jailed for cannabis crimes. Now I've launched my own cannabis company in Michigan. This is my Redemption.”

— Ryan Basore, CEO, Redemption Cannabis Company

LANSING, MICHIGAN, UNITED STATES, March 3, 2020 /EINPresswire.com/ — A new cannabis product line rolls out its commercial presence with a website and series of videos created by two of Michigan's most well-known cannabis figures, Ryan Basore and Rick Thompson.

The videos offer a first-ever look behind the scenes of cannabis businesses in Michigan, including cannabis cultivators and processors. The businesses are all part of the Redemption line of cannabis products, created by Basore after his release from federal prison for cannabis offenses.

In 2019, Basore received a $50,000 grant from Gage Cannabis Company as part of their unique social equity program in Michigan. He used that grant to create the Redemption brand and joined with other drug war victims to create branded flower, concentrates and pre-rolls for the medical and adult-use consumer in Michigan's market.

One video in the series features Truu Cannabis from Lansing, with footage shot on location in their cultivation facility. Other videos feature Driven Grow of Frederick, Real Leaf Cultivators and Fresh Coast Extracts, both from Kalkaska.

The video release coincides with the publication of the Redemption Cannabis Company's website, www.redemptioncanna.com The Redemption website and video series is available online beginning March 3. Due to international shipping obstacles the launch of the Redemption product line will come shortly after, according to Basore, CEO of Lansing-based Redemption.

The all-Michigan video project consists of five different videos, each written and directed by Thompson of Flint; produced and hosted by Basore of Lansing; and featuring videography by Sawyer Harris Productions of Kalamazoo.

Principals from all companies are available for telephone or video interviews and video of cultivation/processing facilities is welcome by verified media sources. Please coordinate all inquiries through the media contact person.

Ryan Basore
Redemption Cannabis Company
+1 517-909-0076
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Video introduction to Redemption Cannabis by Ryan Basore/directed by Rick Thompson


Source: EIN Presswire

Electroshock: Therapy or Torture? Exhibit Held in Tallahassee Rotunda

Children between the ages of 0–5 are being shocked under the guise of “treatment” and the FDA has never required clinical studies that prove electroshock is either safe or effective, despite being used for more than 80 years.

Children between the ages of 0–5 are being shocked under the guise of “treatment” and the FDA has never required clinical studies that prove electroshock is either safe or effective, despite being used for more than 80 years.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

With no clinical trials proving its safety, ECT treatment plays Russian roulette with the lives of vulnerable people who are often ill-informed about its long-term effects, including, according to an ECT device manufacturer, permanent brain damage.

With no clinical trials proving its safety, ECT treatment plays Russian roulette with the lives of vulnerable people who are often ill-informed about its long-term effects, including, according to an ECT device manufacturer, permanent brain damage.

Side effects of ECT include amnesia (substantial and permanent memory loss), confusion, disorientation, apathy, disinterest, headaches, nausea, slowed reaction time, lowered intellectual function and death.

Side effects of ECT include amnesia (substantial and permanent memory loss), confusion, disorientation, apathy, disinterest, headaches, nausea, slowed reaction time, lowered intellectual function and death.

Hundreds of people visited the exhibit learning about the dangers of electroshock with many of them signing a petition to ban this brutal practice.

One fact about ECT: It damages the brain. Period… ECT should have been banned 50 years ago.”

— Dr. Norman Shealy, Neurosurgeon

TALLAHASSEE, FLORIDA, UNITED STATES, March 2, 2020 /EINPresswire.com/ — The Florida chapter of the Citizens Commission on Human Rights (CCHR), a mental health watchdog that investigates and exposes abuses in the mental health industry, held a two-day exhibit on electroconvulsive therapy (ECT), also known as electroshock, in the Florida Capitol last week. According to CCHR, one of the worst abuses in mental health today is the continued use of ECT, particularly on the vulnerable, including children, pregnant women and the elderly. The exhibit provided facts on the dangers of ECT and free copies of a documentary entitled “Therapy or Torture? The Truth about Electroshock”. The documentary, produced by CCHR International, exposes the inhumane practice and its damaging effects, including cognitive and memory dysfunction, neuropathological changes, brain damage and death. [1] [2]

Visiting public and lawmakers learned that ECT sends up to 460 volts of electricity through the brain in order to induce a grand mal seizure, a type of seizure that involves a loss of consciousness and violent muscle contractions, masked by an anesthetic. Many visitors to the exhibit were surprised to find out that the FDA has never required clinical studies that prove electroshock is either safe or effective, despite being used for more than 80 years. [3] Comments from those seeing the exhibit included: “This (ECT) is medieval.” “Why would it be done on young children?” “Why is this done?” Many people did not know electroshock was still practiced in modern times. Several people who stopped by the exhibit related their own personal experience with a friend or family member who was never the same after receiving this “treatment.”

Another fact exposed was while psychiatrists claim modern Electroshock (ECT) is less brutal than it used to be (as accurately portrayed in the Academy-Award-winning film One Flew Over the Cuckoo’s Nest) when patients used to break bones from the violent convulsions it produced, the voltage and amperage in today’s ECT is actually higher. [4] The muscle relaxants now administered make it appear less brutal, but it’s not. The side effects of the most commonly used muscle relaxant for ECT include: cardiac arrest, prolonged respiratory muscle paralysis and potentially life-threatening and/or fatal allergic reactions. [5] [6]

According to Dr. Norman Shealy, Neurosurgeon, “One fact about ECT: It damages the brain. Period… ECT should have been banned 50 years ago.”

CCHR is very much in agreement with this viewpoint and is calling for a ban on the use of the ECT device not just in Florida but across the country. Individuals are encouraged to report instances of damage and death as a result of ECT and to sign the petition to ban ECT in Florida and nationally.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information please visit www.cchrflorida.org.

[1] "Electric shock in pregnancy: a review," The Journal of Maternal-Fetal & Neonatal Medicine, Vol. 29, 2014, Issue 2, http://www.tandfonline.com/doi/abs/10.3109/14767058.2014.1000295?journalCode=ijmf20.
[2] https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/memory-and-cognitive-effects-of-ect-informing-and-assessing-patients/DD5C63934357779765BA7ADF308275AE
[3] Jonathan Emord & Associates, Citizens Petition filed with the FDA Commissioner, 14 Aug. 2016, pp. 14, 27 and 42, http://emord.com/blawg/wp-content/uploads/2016/08/1-ECT-Citizen-Petition.pdf. 4) "An Analysis of Reported Deaths Following Electroconvulsive Therapy in Texas, 1993-1998," 1 Aug 2001, https://ps.psychiatryonline.org/doi/10.1176/appi.ps.52.8.1095
[4] Op. cit., John Breeding, Ph.D., "Electroshocking Children: Why It Should Be Stopped"; John Breeding, Ph.D., "Chapter 9: Electroshock," http://www.wildestcolts.com/psych_opp/d-electroshock/1-shock.html
[5] Nancy Kerner and Joan Prudic, “Current electroconvulsive therapy practice and research in the geriatric population,” Neuropsychiatry (London), Feb 2014, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000084/
[6] Anectine® (Succinylcholine Chloride Injection, USP) Label, FDA.gov, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/008453s027lbl.pdf

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Therapy or Torture—The Truth About Electroshock Preview


Source: EIN Presswire

Peters Praises Trump For Peace Agreement With The Taliban

Sees It As Major Step In Bringing Troops Home

LAS VEGAS, NV, UNITED STATES, March 2, 2020 /EINPresswire.com/ — Today Sam Peters, United States Air Force veteran, Bronze Star recipient, and Republican candidate for Congress in Nevada’s 4th District, praised President Donald J. Trump and his Administration for the historic peace agreement with the Taliban that if fully kept by the Taliban could end America’s longest war and bring our troops home from Afghanistan. Peters said the agreement ensures that if the Taliban violate any provision of the peace agreement, the United States would nullify the agreement at once. Peters said the agreement if kept will ensure the two most critical components that any peace agreement with the Taliban must have – a solid guarantee that Afghanistan will never again be used as a haven for terrorist organizations to strike at the United States and its interests; and a mechanism to bring our service men and women home ending our involvement in the conflict that has lasted 19 years.

“I want to commend President Trump for reaching this historic agreement with the Taliban,” said Sam Peters. “Having served in Afghanistan and personally carried multiple flag draped coffins onto aircraft for repatriation, I know firsthand the horrors of this conflict. The Taliban have posed significant threat to the US homeland through their network of terror. It’s vital that we monitor progress of implementing this agreement. But, it’s time…and this is a logical first step to bring our troops home.

“I have no illusions about the Taliban, nor does President Trump,” continued Peters. “President Trump is following Ronald Reagan’s mantra of ‘trust but verify.’ If the Taliban violate any part of this agreement, it will be instantly voided. The President and his negotiators have multiple actions in this peace agreement that Taliban must meet for it to be fully implemented. The most important is ensuring that Afghanistan must never again be a haven or launching pad for any terrorist organization against the Unites States, its interests, and its allies. We owe that not only to our citizens but to those that perished on 9/11 and to those who have sacrificed their lives in Afghanistan for our nation to reach this moment.

“If the Taliban keep this agreement, it will ensure something that is near and dear to my heart as a veteran is achieved – bringing our troops home safely to their families,” concluded Peters. “Ending this war and bringing our brave men and women home while ensuring the safety of our nation will be achieved in this agreement if the Taliban abide by it.”

Peters is a veteran of the United States Air Force. He served his country in Afghanistan, Iraq, Panama, and Korea. He earned the Bronze Star for his efforts in Afghanistan.

After his service to our nation, Peters worked for two years as a corporate employee where he managed nearly $100 million in annual revenue across the largest geographical region in the United States. Peters settled in Las Vegas with his family, and exercising his entrepreneurial spirit, Peters founded Peters Family Insurance with two locations. He presently employs eight.

He earned his bachelor’s degree in Criminal Justice Administration, graduating Magna Cum Laude from Park University. He finished his Master of Science in Administration, with focus on law, through Central Michigan University. His continued thirst for knowledge, has also led him through a Graduate-Level Certificate Program in Organizational Finance from the University of Maryland University College.

David Johnson
Strategic Vision PR Group
+1 404-380-1079
email us here


Source: EIN Presswire

SDVOSB Maness Veteran Medical Partners with MolecuLight to Distribute its i:X® Real-Time Fluorescence Wound Imaging

Maness Veteran Medical SDVOSB

SDVOSB Maness Veteran Medical Partners with MolecuLight to Distribute its i:X® Real-Time Fluorescence Wound Imaging Platform to the DoD and VA

ASHEVILLE, NC, USA, March 2, 2020 /EINPresswire.com/ — MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces that Maness Veteran Medical will be its partner to distribute its i:X real-time fluorescence wound imaging platform to the US Department of Defense (DoD) and Veterans Affairs (VA). Maness Veteran Medical (MVM), a proud SDVOSB (Service-Disabled Veteran-Owned Small Business), is led by veteran and amputee Johnathan Maness. Johnathan and MVM spend a tremendous amount of time in VA and DoD facilities researching and creating valuable relationships and are excited to bring MolecuLight's life-saving and affordable technology to these organizations.

Maness Veteran Medical CEO, Johnathan Maness states, "It is imperative that US military veterans and active duty military personnel alike have access to the latest in clinical technologies. In the past, innovative technology has trickled down to veterans, sometimes after having been commercially available for 3-5 years. It has always been my goal to speed this process up for my fellow brothers and sisters. I believe that the MolecuLight i:X is a major breakthrough in wound care diagnostics and am thrilled to be providing this technology to the DoD and VA".

Maness Veteran Medical offers the highest quality products in the medical and pharmaceutical fields. Through the creation of valuable partnerships, MVM is focused on supplying the Unites States’ VA and DoD hospitals with impeccable products and stellar customer service. A benchmark to the industry, MVM’s dedication to the USA and its service persons and veterans remains unprecedented.

About MolecuLight Inc.
MolecuLight Inc. (www.moleculight.com) is a privately owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s first commercially released device, the MolecuLight i:X®, and its accessories deliver a real-time handheld fluorescence imaging solution for the global wound care market. The MolecuLight i:X provides clinicians with information about the fluorescent characteristics of wounds containing bacteria to assist in making improved diagnostic and treatment decisions. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

MolecuLight operates worldwide through its Headquarters and subsidiaries in various countries including MolecuLight Inc. (Canada), MolecuLight Corp. (USA), MolecuLight GmbH (Germany), MolecuLight France, MolecuLight UK Ltd., MolecuLight Italy S.R.L., and MolecuLight Holland B.V. Each of these entities is supported by local MolecuLight Sales and Clinical Applications teams who support customers by providing clinical demonstrations, by delivering MolecuLight’s comprehensive training program and by supporting the ongoing adoption of the i:X device.

Johnathan Maness
Maness Veteran Medical
+ +1 7274525452
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

Local Health Departments Urge Adoption of Funding to Strengthen Public Health Capacity to Respond to Coronavirus Spread

Lori Tremmel Freeman, CEO

Millions in uncovered costs already incurred as health departments prepare for and respond to potential and confirmed cases

WASHINGTON, DC, UNITED STATES, March 2, 2020 /EINPresswire.com/ — The National Association of County and City Health Officials (NACCHO), on behalf of the nation’s 3,000 local health departments, sent the following letter to Congress urging it to quickly pass a robust emergency supplemental funding that includes specific resources to support the work of public health departments to activate for and respond to the coronavirus. A full copy of the letter, include an extensive list of activities and supplies that need funding) can be found here.

The National Association of County and City Health Officials (NACCHO) urges Congress to quickly adopt efforts to support and strengthen local, state, federal, territorial, tribal, and global public health capacity and coordination to adequately respond to this infectious disease outbreak.

A wide range of potential funding amounts have been suggested in recent days by both the Administration and Members of Congress. While it is difficult to accurately predict the future cost of response efforts due to many unknowns about the future scale and spread of the outbreak in the United States, local health departments are already activated and incurring costs related to their work to address potential and future cases in their communities. Therefore, we strongly recommend a robust emergency supplemental package that specifically delineates strong funding to support the work that local, state, tribal and territorial health departments have and continue to do as part of this response. Funds are needed to support a wide range of activities, including, but not limited to:

• Isolation/quarantine related activities, including securing and standing up facilities, transportation and lodging and wrap around services like behavioral health services/support, counseling, or even necessities like food, toiletries, etc.

• Testing and monitoring patients that are currently under investigation (PUIs), rapidly investigating cases, and obtaining information on their close contacts.

• Outreach to the general public, including media buys for public communication, collaboration with community organizations, printing, phone banks, updating web information, and translating materials into appropriate languages.

• Engagement with hospital, healthcare system, and health plan leaders to monitor healthcare staffing and supplies; implement plans to reduce demands on the healthcare system.
• Acquisition of personal protective equipment (PPE), and other equipment like thermometers.
• Laboratory testing equipment, supplies, and support personnel.
• Data analytics and epidemiological surveillance system capacity.
• Implementing seamless, interoperable data sharing across the public health infrastructure.

In addition, we request that emergency supplemental appropriations provide funding to reimburse costs that were redirected from other programs, consistent with the structure of past emergency supplemental appropriations. Lastly, funding should not be offset by cutting other public health or human service programs, and any existing programs or grants from which funds are diverted or transferred in the near-term response should be replenished by the emergency supplemental appropriation.

While supplemental funding will support critical activities to rapidly respond to the COVID-19 outbreak, it does not preclude the need for Congress to provide sustained, continued, and increased investments through the annual appropriations process for HHS to expand capacity to address other existing and future public health threats. Strong, sustainable funding is critical to increase the capacity of health departments who have lost nearly a quarter of their workforce since 2008.

NACCHO and local health departments look forward to working with Congress to address this global outbreak that has the potential to spread throughout our communities, disrupting families, workplaces, and the U.S. economy. Without medical countermeasures, our most effective prevention efforts to minimize widespread illness and loss of life include community mitigation activities that require intensive work by trained public health professionals. Any delay in these efforts can result in a huge human and economic cost.

###

About NACCHO
The National Association of County and City Health Officials (NACCHO) represents the nation's nearly 3,000 local governmental health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit www.naccho.org.

Theresa Spinner
National Association of County and City Health Officials
+1 202-783-5551
email us here
Visit us on social media:
Twitter


Source: EIN Presswire